Toru Otsuru
Matsuyama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: results from an open-label, phase II study.
Journal: ESMO gastrointestinal oncology
Published: August 12, 2026
Randomized phase III trial of gemcitabine plus nab-paclitaxel versus gemcitabine plus S-1 as neoadjuvant chemotherapy for resectable pancreatic cancer in geriatric patients: JCOG2101C (PRESTIGE study).
Journal: Japanese journal of clinical oncology
Published: January 06, 2026
Clinicopathological features for clinically resectable peripherally located pancreatic ductal adenocarcinoma.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: April 15, 2025
A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy.
Journal: International journal of clinical oncology
Published: October 11, 2024
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Journal: British journal of cancer
Published: October 14, 2022
Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study.
Journal: Cancer chemotherapy and pharmacology
Published: January 31, 2020
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.
Journal: British journal of cancer
Published: July 06, 2019
Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report.
Journal: World journal of gastrointestinal oncology
Published: May 16, 2019
Nivolumab-induced interstitial lung disease in a patient with gastric cancer.
Journal: Oxford medical case reports
Published: October 10, 2018
Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.
Journal: Cancer science
Published: February 28, 2018
A Case of Hepatocellular Carcinoma with Right Atrium Tumor Thrombus and Multiple Intrahepatic Metastases That Remarkably Responded to Combination Therapy Including Surgery
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 25, 2018
Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma.
Journal: International journal of oncology
Published: February 06, 2017
Last Updated: 09/26/2026